FDA Asks Correlogic Systems for a Meeting on Marketing of its Ovarian Cancer Test | GenomeWeb

NEW YORK, Feb. 25 (GenomeWeb News) - Steve Gutman, the director of the US Food and Drug Administration's Office of In Vitro  Diagnostic Device Evaluation and Safety, has asked Correlogic Systems to discuss the marketing of the company's test for predicting ovarian cancer, GenomeWeb News  has learned.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.